Rudolf Kwan, EVP, Chief Medical Officer at Athenex, Inc. (ATNX), bought 4,000 shares at $2.05 ($8K) on 2021-11-16, disclosed to the SEC on 2021-11-17.
Open-market purchase of $8k ATNX by EVP, Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| Filing → |
| ATNX | BUY | 2020-03-13 | $16K | — | Filing → |
| ATNX | BUY | 2020-03-10 | $20K | — | Filing → |
| ATNX | BUY | 2019-08-16 | $15K | — | Filing → |